THE DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS: A NEW LOOK


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper presents the current principles of the diagnosis and treatment of endometriosis, as well as the latest methods that are only to be introduced into daily gynecological practice.

全文:

受限制的访问

作者简介

A. Solopova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: antoninasolopova@yandex.ru

E. Chukanova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

参考

  1. Dunselman G., Vermeulen N., Becker C. et al. ESHRE guideline: management of women with endometriosis // Hum. Reprod. - 2014; 29 (3): 400-12.
  2. Guerriero S., Ajossa S., Gerada M. et al. Diagnostic value of transvaginal ‘tenderness-guided’ ultrasonography for the prediction of location of deep endometriosis // Hum. Reprod. - 2008; 23 (11): 2452-7.
  3. Berker B., Seval M. Problems with the diagnosis of endometriosis // Womens Health (Lond). - 2015; 11 (5): 597-601.
  4. Lee N., Kim S., Kim K. et al. Diffusion-weighted magnetic resonance imaging in the differentiation of endometriomas from hemorrhagic cysts in the ovary // Acta Radiologica. - 2016; 57 (8): 998-1005.
  5. Пантелеева О.Г., Кузнецова И.А., Качалина О.В. и др. Оптическая когерентная томография как инструмент репродуктивной гинекологии // Современ. технол. в медицине. - 2015; 1: 89-96.
  6. Маржевская А.М., Рищук С.В., Гусев С.Н. и др. Репродуктивные нарушения у больных эндометриозом: этиология, патогенез, возможности коррекции // БОНЦ УрО РАН. - 2014; 3: 1-42.
  7. Ярмолинская М.И., Молотков А.С., Денисова В.М. Роль матриксных металлопротеиназ в патогенезе генитального эндометриоза // Журн. акушерства и женских болезней. - 2012; 61 (2): 92-100.
  8. Turkyilmaz E., Yildirim M., Cendek B. et al. Evaluation of oxidative stress markers and intra-extracellular antioxidant activityes in patients with endometriosis // Eur. J. Obstet. Gynecol. Reprod. Biol. - 2016; 199: 164-8.
  9. Сорокина А.В., Радзинский В.Е., Морозов С.Г. и др. Информативность иммунологических показателей в сыворотке крови для диагностики аденомиоза // Доктор.ру. - 2012; 1 (69): 7-9.
  10. Влияние хирургического лечения эндометриомы яичников на овариальный резерв: итоги систематического обзора и метаанализа // Пробл. женского здоровья. - 2012; 3.
  11. Vercellini P., Eskenazi B., Consonni D. et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis // Hum. Reprod. Update. -2011; 17 (2): 159-70.
  12. Kaminski K., Fiegler P., Marr J. et al. Treatment of endometriosis with dienogest: preliminary report // Ginekol. Pol. - 2001; 72: 299-304.
  13. Mita S., Shimizu Y., Sato A. et al. Dienogest in hibits nervegrowth factor expression induced by tumor necrosis factor-а or interleukin-1 ß // Fertil. Steril. -2014; 101 (2): 595-601.
  14. Carr B., Dmowski W., Brien C. et al. Anoral-Gn-R-Hantagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density // Reprod. Sci. - 2014; 21 (11): 1341-51.
  15. Nakata D., Masaki T., Tanaka A. et al. Suppression of the hypothalamic-pituitary-gonadalaxisby TAK-385 (relugolix), a novel, investigational, orallyactive, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRHreceptorknock-inmice // Eur. J. Pharmacol. - 2014; 723: 167-74.
  16. Delvoux B., D'hooghe T., Kyama C. et al. Inhibitionoftype 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions // J. Clin. Endocrinol. Metabol. - 2014; 99 (1): 276-84.
  17. Kulak J., Fischer C., Komm B. et al. Treatment with bazed oxifene, a selective estrogen receptor modulator, causes regression of endometriosisin a mouse model // Endocrinology. - 2011; 152 (8): 3226-32.
  18. Zhao Y., Gong P., Chen Y. et. al. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis // Sci. Translat. Med. - 2015; 7 (271): 1-14.
  19. Imesch P., Samartzis E., Dedes K. et al. Histone deacetylase inhibitors down-regulate G-protein- coupled estrogen receptor and the GPER-antagonist G-15 inhibits prolife rationin endometriotic cells // Fertil. Steril. - 2013; 100: 770-6.
  20. Benagiano G., Bastianelli C., Farris M. et al. Selective progesterone receptor modulators: an update // Expert Opin. Pharmacother. - 2014; 15 (10): 1403-15.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2017
##common.cookie##